Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Manufacturer

Eugia US LLC

73 drugs, 93 product strengths, 17 recalls on record.

Drugs Eugia US LLC makes

Furosemide-4.2%Generic · 52 makersPharmacies pay from$0.75Unavailable3 open recallsPantoprazole+2.7%Generic · 62 makersPharmacies pay from$1.103 open recallsEsomeprazole-3.4%Generic · 107 makersPharmacies pay from$3.844 open recallsSildenafil+2.3%Generic · 54 makersPharmacies pay from$1.572 open recallsNaloxone-1.6%Generic · 42 makersPharmacies pay from$12.541 open recallAzithromycin+0.9%Generic · 45 makersPharmacies pay from$1.63Being discontinuedLevetiracetam-1.9%Generic · 63 makersPharmacies pay from$1.702 open recallsHydralazine-1.0%Generic · 37 makersPharmacies pay from$0.78In shortage3 open recallsOlanzapine+1.3%Generic · 35 makersPharmacies pay from$2.432 open recallsSumatriptan+3.4%Generic · 39 makersPharmacies pay from$7.60Methocarbamol-2.1%Generic · 57 makersPharmacies pay from$1.162 open recallsTriamcinolone-0.9%Generic · 70 makersPharmacies pay from$0.67In shortage15 open recallsDexamethasone+3.2%Generic · 59 makersPharmacies pay from$1.19Unavailable10 open recallsMethylprednisolone-4.0%Generic · 25 makersPharmacies pay from$3.03Unavailable5 open recallsMedroxyprogesterone+0.2%Generic · 23 makersPharmacies pay from$3.45Being discontinued5 open recallsTestosterone-3.4%Generic · 29 makersPharmacies pay from$35.2068 open recallsProgesterone+1.7%Generic · 25 makersPharmacies pay from$6.99Being discontinued4 open recallsLidocaine-1.8%Generic · 396 makersPharmacies pay from$1.74Unavailable59 open recallsAcetaminophen+1.6%Generic · 255 makersPharmacies pay from$0.6619 open recallsPhenylephrine-2.3%Generic · 81 makersPharmacies pay from$1.4517 open recallsTobramycin-1.1%Generic · 42 makersPharmacies pay from$5.48Being discontinued6 open recallsProchlorperazine-1.9%Generic · 41 makersPharmacies pay from$3.351 open recallTranexamic acid-1.6%Generic · 39 makersPharmacies pay from$24.882 open recallsCaffeine-0.1%Generic · 37 makersPharmacies pay from$2.49Fluphenazine+59.4%Generic · 30 makersPharmacies pay from$7.0910 open recallsVoriconazole+8.8%Generic · 30 makersPharmacies pay from$25.005 open recallsPosaconazole+1.7%Generic · 28 makersPharmacies pay from$62.01Being discontinued1 open recallRocuroniumGeneric · 27 makersNo weekly priceUnavailable1 open recallDaptomycin+7.4%Generic · 25 makersPharmacies pay from$25.56Being discontinued2 open recallsGentamicin+14.9%Generic · 23 makersPharmacies pay from$2.525 open recallsLinezolid+2.3%Generic · 23 makersPharmacies pay from$44.22SuccinylcholineGeneric · 23 makersNo weekly priceBeing discontinued4 open recallsEphedrineGeneric · 22 makersNo weekly price1 open recallNicardipine+2.6%Generic · 21 makersPharmacies pay from$34.466 open recallsBortezomibGeneric · 21 makersNo weekly price1 open recallCarboprostGeneric · 21 makersNo weekly priceThiamine-5.4%Generic · 20 makersPharmacies pay from$1066 open recallsZoledronic acid-2.0%Generic · 20 makersPharmacies pay from$46.571 open recallAzacitidineGeneric · 20 makersNo weekly priceUnavailable1 open recallFluorouracil+5.2%Generic · 18 makersPharmacies pay from$25.89FulvestrantGeneric · 20 makersNo weekly priceBeing discontinuedDecitabineGeneric · 18 makersNo weekly priceBeing discontinued1 open recallFosaprepitantGeneric · 17 makersNo weekly priceBeing discontinuedErtapenem-6.5%Generic · 16 makersPharmacies pay from$2491 open recallAcetylcysteine+4.2%Generic · 13 makersPharmacies pay from$96.564 open recallsAmpicillin-0.3%Generic · 13 makersPharmacies pay from$13.20Being discontinued1 open recallPiperacillin / tazobactamNo changeGeneric · 13 makersPharmacies pay from$34.93Being discontinuedBivalirudinGeneric · 13 makersNo weekly priceMeropenem+7.6%Generic · 12 makersPharmacies pay from$50.431 open recallArgatrobanGeneric · 12 makersNo weekly price2 open recallsPalonosetronGeneric · 12 makersNo weekly priceBeing discontinuedPlerixaforGeneric · 12 makersNo weekly priceBeing discontinuedLeuprolideNo changeGeneric · 10 makersPharmacies pay from$198Being discontinuedKetamine+1.4%Generic · 9 makersPharmacies pay from$55.638 open recallsAmpicillin / sulbactamGeneric · 10 makersNo weekly priceArsenic trioxideGeneric · 10 makersNo weekly priceBeing discontinuedCarboplatinGeneric · 10 makersNo weekly priceUnavailableIbandronate+3.4%Generic · 9 makersPharmacies pay from$82.97Vasopressin (USP)Generic · 10 makersNo weekly priceVecuroniumGeneric · 10 makersNo weekly price2 open recallsClofarabineGeneric · 9 makersNo weekly priceBusulfanGeneric · 7 makersNo weekly price1 open recallIcatibantGeneric · 7 makersNo weekly priceBeing discontinuedMesnaGeneric · 7 makersNo weekly pricePolymyxin BGeneric · 7 makersNo weekly price5 open recallsFondaparinux-5.2%Generic · 5 makersPharmacies pay from$111NafcillinGeneric · 6 makersNo weekly price4 open recallsAmphotericin BGeneric · 5 makersNo weekly price1 open recallTigecyclineGeneric · 5 makersNo weekly priceDactinomycinGeneric · 4 makersNo weekly priceOxacillinGeneric · 4 makersNo weekly price3 open recallsDexrazoxaneGeneric · 2 makersNo weekly price17-alpha-hydroxyprogesteroneGeneric · 1 makerNo weekly price

Recalls

Class IIIOngoingJun 10, 2026Lidocaine HCl InjectionLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scanEugia US LLC · D-0552-2026Class IIOngoingJun 25, 2025Gentamicin InjectionFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.Eugia US LLC · D-0472-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 12.5 mg/250 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0390-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 5 mg/100 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0389-2025Class IIOngoingApr 23, 2025Testosterone Cypionate InjectioncGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.Eugia US LLC · D-0363-2025Class IIOngoingJan 15, 2025medroxyPROGESTERone Acetate Injectable SuspensionCGMP DeviationsEugia US LLC · D-0185-2025Class IIOngoingJan 15, 2025Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.Eugia US LLC · D-0186-2025Class IIOngoingAug 7, 2024Progesterone InjectionPresence of Particulate Matter: Complaint received of a glass particle in the vial.Eugia US LLC · D-0624-2024Class IIOngoingJun 26, 2024Dexamethasone Sodium Phosphate injection USPFailed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.Eugia US LLC · D-0555-2024Class IIIOngoingJun 26, 2024Eptifibatide injection 20mg/10mLFailed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.Eugia US LLC · D-0556-2024Class IOngoingApr 17, 2024Methocarbamol InjectionPresence of Particulate MatterEugia US LLC · D-0440-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0391-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0390-2024Class IITerminatedMar 20, 2024Tobramycin for InjectionFailed Stability Specification: Water determination was found not complying with specification.Eugia US LLC · D-0385-2024Class IIOngoingMar 13, 2024Methylprednisolone acetate Injectable SuspensionFailed Dissolution SpecificationsEugia US LLC · D-0366-2024Class IIOngoingOct 11, 2023Triamcinolone Acetonide Injectable SuspensionPresence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.Eugia US LLC · D-0041-2024Class IIOngoingJan 11, 2023Acyclovir Sodium Injection 1Presence of Particulate Matter: Customer complaint of dark particles found inside the vialEugia US LLC · D-0095-2023

About Eugia US LLC

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.